These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1834644)

  • 1. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.
    Dripps DJ; Verderber E; Ng RK; Thompson RC; Eisenberg SP
    J Biol Chem; 1991 Oct; 266(30):20311-5. PubMed ID: 1834644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.
    Granowitz EV; Clark BD; Mancilla J; Dinarello CA
    J Biol Chem; 1991 Aug; 266(22):14147-50. PubMed ID: 1830582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells.
    Scapigliati G; Ghiara P; Bartalini M; Tagliabue A; Boraschi D
    FEBS Lett; 1989 Jan; 243(2):394-8. PubMed ID: 2521831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 (IL-1) receptors on murine splenic B cells and the 70Z/3 pre-B-cell line appear to be identical and bind human IL-1 alpha and IL-1 beta differentially.
    Powers GD; Varnell TA; Kaffka KL; Chizzonite R; Kilian PL
    Lymphokine Cytokine Res; 1992 Apr; 11(2):123-32. PubMed ID: 1533794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    McColl SR; Paquin R; Ménard C; Beaulieu AD
    J Exp Med; 1992 Aug; 176(2):593-8. PubMed ID: 1386877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and identification of interleukin 1 receptors on bovine neutrophils.
    Lederer JA; Czuprynski CJ
    J Leukoc Biol; 1992 Jun; 51(6):586-90. PubMed ID: 1535356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of type-II interleukin-1 receptors. Heterogeneity of B-cell interleukin-1 binding created by dimerization of type-II interleukin-1 receptors.
    Cronkhite RI; Lobick JJ; Plate JM
    Hum Immunol; 1993 Feb; 36(2):128-36. PubMed ID: 8463123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism.
    Eisenberg SP; Brewer MT; Verderber E; Heimdal P; Brandhuber BJ; Thompson RC
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5232-6. PubMed ID: 1828896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
    Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
    Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells.
    Arend WP; Coll BP
    Cytokine; 1991 Sep; 3(5):407-13. PubMed ID: 1836395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.
    Dripps DJ; Brandhuber BJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1991 Jun; 266(16):10331-6. PubMed ID: 1828071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit interleukin-1 receptor antagonist. Cloning, expression, functional characterization, and regulation during intestinal inflammation.
    Cominelli F; Bortolami M; Pizarro TT; Monsacchi L; Ferretti M; Brewer MT; Eisenberg SP; Ng RK
    J Biol Chem; 1994 Mar; 269(9):6962-71. PubMed ID: 7509813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-specific binding of IL-1, but not the IL-1 receptor antagonist, by fibroblasts.
    Lederer JA; Czuprynski CJ
    Cytokine; 1994 Mar; 6(2):154-61. PubMed ID: 8031998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a novel soluble receptor for interleukin 1.
    Symons JA; Eastgate JA; Duff GW
    J Exp Med; 1991 Nov; 174(5):1251-4. PubMed ID: 1834761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
    Svenson M; Hansen MB; Heegaard P; Abell K; Bendtzen K
    Cytokine; 1993 Sep; 5(5):427-35. PubMed ID: 8142597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
    Vannier E; Miller LC; Dinarello CA
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.